Lite Strategy, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 348.20M shares, a 1522744.75% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 246.50K shares, a 291.56% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 22.86K shares, a 78.63% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 62.95K shares.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 348.55M shares, a 245516.50% increase from fiscal 2021.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 141.91K shares, a 7.66% decline from fiscal 2020.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 153.68K shares, a 35.38% decline from fiscal 2019.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 237.81K shares, a 23.26% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-06-30 | 348.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | 348.55M shares 10-K · filed 2022-09-08 |
| 2022-03-31 | 246.50K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-05-23 | |
| 2021-06-30 | 22.86K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-23 | 141.91K shares 10-K/A · filed 2022-05-23 |
| 2021-03-31 | 62.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | 226.05K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 5.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | 163.10K shares derived: sum of 4 quarters · filed 2021-02-04 |
| 2020-09-30 | 50.23K shares 10-Q · filed 2020-11-10 | 157.24K shares derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | 107.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | 153.68K shares 10-K · filed 2020-09-09 |
| 2020-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | 56.55K shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | 245.10K shares derived: sum of 4 quarters · filed 2020-02-06 |
| 2019-09-30 | 46.67K shares 10-Q · filed 2019-11-07 | 261.14K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 9.88K shares derived: 10-K 12 month − 3 quarters · filed 2019-08-28 | 237.81K shares 10-K · filed 2019-08-28 |
| 2019-03-31 | 188.55K shares 10-Q · filed 2019-05-09 | 307.48K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 16.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | 118.92K shares derived: sum of 4 quarters · filed 2019-02-07 |
| 2018-09-30 | 23.34K shares 10-Q · filed 2018-11-08 | 205.07K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 79.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | 192.94K shares 10-K · filed 2018-08-30 |
| 2018-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | |
| 2017-12-31 | 102.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | |
| 2017-09-30 | 11.21K shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 0.00 shares 10-K · filed 2017-09-05 | |
| 2016-06-30 | 0.00 shares 10-K · filed 2017-09-05 | |
| 2015-06-30 | 0.00 shares 10-K · filed 2017-09-05 | |
| 2014-06-30 | 0.00 shares 10-K · filed 2016-09-06 | |
| 2013-06-30 | 0.00 shares 10-K · filed 2015-09-02 | |
| 2012-06-30 | 0.00 shares 10-K · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |